The stem cell assay market size has grown exponentially in recent years. It will grow from $2.84 billion in 2025 to $3.48 billion in 2026 at a compound annual growth rate (CAGR) of 22.4%. The growth in the historic period can be attributed to increase in stem cell research, academic funding growth, drug discovery demand, laboratory automation adoption, regenerative medicine trials.
The stem cell assay market size is expected to see exponential growth in the next few years. It will grow to $7.74 billion in 2030 at a compound annual growth rate (CAGR) of 22.1%. The growth in the forecast period can be attributed to cell-based therapy development, assay standardization demand, pharmaceutical screening applications, ai-enabled assay analysis, emerging biotech startups. Major trends in the forecast period include high-throughput assay platforms, functional stem cell analysis, integration with omics technologies, automated cell viability testing, standardized assay kits.
The rising prevalence of chronic diseases is expected to drive growth in the stem cell assay market in the coming years. Chronic diseases are illnesses that typically last three months or longer and may worsen over time. Stem cells offer potential treatments for a wide range of conditions, including chronic diseases, by supporting the development of new antibodies and specialized cells that help address ailments such as cancer. For example, in March 2024, the Government of the United Kingdom reported that in the financial year ending 2023, slightly over 1,862,500 people in England, representing 3% of the population, had a GP diagnosis of coronary heart disease (CHD). Consequently, the increasing prevalence of chronic diseases is driving growth in the stem cell assay market.
Leading companies in the stem cell assay market are emphasizing technological innovations, such as next-generation tissue dissociation and sample preparation systems, to improve cell viability, processing efficiency, and reproducibility across research applications. Advanced dissociation platforms enable automated, gentle, and standardized processing of complex tissues, producing high-quality single-cell suspensions critical for downstream stem cell research, regenerative medicine, and cell-based assays. For instance, in June 2025, STEMCELL Technologies, a Canada-based biotechnology company specializing in stem cell research tools, launched the STEMprep Tissue Dissociator System, an integrated mechanical and enzymatic dissociation platform designed to streamline and accelerate tissue processing workflows. The system offers programmable protocols, closed-system handling, and consistent cell yields, helping researchers reduce processing time, minimize variability, and improve assay reliability while advancing discoveries in stem cell biology and translational research.
In June 2025, STEMCELL Technologies, a Canada-based provider of specialty cell culture media, reagents, and research tools, acquired Cellular Highways Ltd for an undisclosed amount. Through this acquisition, STEMCELL Technologies aims to enhance its cell processing and cell therapy manufacturing capabilities by incorporating advanced microfluidics-based cell sorting platforms, accelerating innovation in scalable, high-throughput research workflows, and expanding its portfolio of tools for translational and clinical applications. Cellular Highways Ltd, based in the UK, specializes in high-speed microfluidic cell sorting technologies that improve cell separation accuracy and processing efficiency.
Major companies operating in the stem cell assay market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., PerkinElmer Inc., Agilent Technologies Inc., Promega Corporation, Cell Biolabs Inc., Miltenyi Biotec GmbH, STEMCELL Technologies Inc., Bio-Techne Corporation, Charles River Laboratories International Inc., Hemogenix Inc., Lonza Group AG, Takara Bio Inc., Creative Bioarray, AAT Bioquest Inc., BPS Bioscience Inc., Enzo Life Sciences Inc., PromoCell GmbH, Biotium Inc., Geno Technology Inc., Abcam plc, ReachBio Research Labs. Inc., Sartorius AG, Eppendorf AG, Corning Incorporated, MEDIPOST Co. Ltd., Anterogen Co. Ltd., Corestemchemon Inc., Pharmicell Inc., NuVasive Inc., RTI Surgical Holdings Inc., AlloSource LifeSource Services Inc., JCR Pharmaceuticals Co. Ltd.
North America was the largest region in the stem cell assay market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell assay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the stem cell assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have raised costs in the stem cell assay market by increasing prices for imported reagents, detection kits, flow cytometers, and analytical instruments. Research institutes and biotechnology companies in Asia-Pacific and Europe are most impacted due to dependence on international laboratory suppliers. These higher costs can slow stem cell research and assay adoption. At the same time, tariffs are encouraging local production of assay kits and instruments, strengthening long-term research capacity.
The stem cell assay market research report is one of a series of new reports that provides stem cell assay market statistics, including stem cell assay industry global market size, regional shares, competitors with a stem cell assay market share, detailed stem cell assay market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell assay industry. This stem cell assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Stem cells are cells with the unique ability to self-renew and develop into specialized cell types, serving as the fundamental building blocks of all living organisms. Stem cell assays are designed to study human stem cell growth and analyze their biological activities in a controlled environment.
The main types of stem cell assays include cell viability and toxicity assays, cell apoptosis assays, cell function assays, cell identification assays, isolation and purification assays, cell differentiation assays, and others. Cell viability and toxicity assays evaluate the physical and physiological health of cells in response to external stimuli, chemical agents, medical treatments, or other conditions, and help determine optimal conditions for cell culture growth. The products used include instruments and detection kits, applied in areas such as regenerative medicine and therapy development, drug discovery and development, and clinical research. End users include government research institutes, private research institutes, and industrial research organizations.
The stem cell assay market consists of sales of tetrazolium reduction assays, resazurin cell viability assays, calcein-AM cell viability assays, proliferation assays, differentiation assays, function assays, caspase assays and annexin v and cell permeability assays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The stem cell assay market size is expected to see exponential growth in the next few years. It will grow to $7.74 billion in 2030 at a compound annual growth rate (CAGR) of 22.1%. The growth in the forecast period can be attributed to cell-based therapy development, assay standardization demand, pharmaceutical screening applications, ai-enabled assay analysis, emerging biotech startups. Major trends in the forecast period include high-throughput assay platforms, functional stem cell analysis, integration with omics technologies, automated cell viability testing, standardized assay kits.
The rising prevalence of chronic diseases is expected to drive growth in the stem cell assay market in the coming years. Chronic diseases are illnesses that typically last three months or longer and may worsen over time. Stem cells offer potential treatments for a wide range of conditions, including chronic diseases, by supporting the development of new antibodies and specialized cells that help address ailments such as cancer. For example, in March 2024, the Government of the United Kingdom reported that in the financial year ending 2023, slightly over 1,862,500 people in England, representing 3% of the population, had a GP diagnosis of coronary heart disease (CHD). Consequently, the increasing prevalence of chronic diseases is driving growth in the stem cell assay market.
Leading companies in the stem cell assay market are emphasizing technological innovations, such as next-generation tissue dissociation and sample preparation systems, to improve cell viability, processing efficiency, and reproducibility across research applications. Advanced dissociation platforms enable automated, gentle, and standardized processing of complex tissues, producing high-quality single-cell suspensions critical for downstream stem cell research, regenerative medicine, and cell-based assays. For instance, in June 2025, STEMCELL Technologies, a Canada-based biotechnology company specializing in stem cell research tools, launched the STEMprep Tissue Dissociator System, an integrated mechanical and enzymatic dissociation platform designed to streamline and accelerate tissue processing workflows. The system offers programmable protocols, closed-system handling, and consistent cell yields, helping researchers reduce processing time, minimize variability, and improve assay reliability while advancing discoveries in stem cell biology and translational research.
In June 2025, STEMCELL Technologies, a Canada-based provider of specialty cell culture media, reagents, and research tools, acquired Cellular Highways Ltd for an undisclosed amount. Through this acquisition, STEMCELL Technologies aims to enhance its cell processing and cell therapy manufacturing capabilities by incorporating advanced microfluidics-based cell sorting platforms, accelerating innovation in scalable, high-throughput research workflows, and expanding its portfolio of tools for translational and clinical applications. Cellular Highways Ltd, based in the UK, specializes in high-speed microfluidic cell sorting technologies that improve cell separation accuracy and processing efficiency.
Major companies operating in the stem cell assay market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., PerkinElmer Inc., Agilent Technologies Inc., Promega Corporation, Cell Biolabs Inc., Miltenyi Biotec GmbH, STEMCELL Technologies Inc., Bio-Techne Corporation, Charles River Laboratories International Inc., Hemogenix Inc., Lonza Group AG, Takara Bio Inc., Creative Bioarray, AAT Bioquest Inc., BPS Bioscience Inc., Enzo Life Sciences Inc., PromoCell GmbH, Biotium Inc., Geno Technology Inc., Abcam plc, ReachBio Research Labs. Inc., Sartorius AG, Eppendorf AG, Corning Incorporated, MEDIPOST Co. Ltd., Anterogen Co. Ltd., Corestemchemon Inc., Pharmicell Inc., NuVasive Inc., RTI Surgical Holdings Inc., AlloSource LifeSource Services Inc., JCR Pharmaceuticals Co. Ltd.
North America was the largest region in the stem cell assay market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell assay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the stem cell assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have raised costs in the stem cell assay market by increasing prices for imported reagents, detection kits, flow cytometers, and analytical instruments. Research institutes and biotechnology companies in Asia-Pacific and Europe are most impacted due to dependence on international laboratory suppliers. These higher costs can slow stem cell research and assay adoption. At the same time, tariffs are encouraging local production of assay kits and instruments, strengthening long-term research capacity.
The stem cell assay market research report is one of a series of new reports that provides stem cell assay market statistics, including stem cell assay industry global market size, regional shares, competitors with a stem cell assay market share, detailed stem cell assay market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell assay industry. This stem cell assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Stem cells are cells with the unique ability to self-renew and develop into specialized cell types, serving as the fundamental building blocks of all living organisms. Stem cell assays are designed to study human stem cell growth and analyze their biological activities in a controlled environment.
The main types of stem cell assays include cell viability and toxicity assays, cell apoptosis assays, cell function assays, cell identification assays, isolation and purification assays, cell differentiation assays, and others. Cell viability and toxicity assays evaluate the physical and physiological health of cells in response to external stimuli, chemical agents, medical treatments, or other conditions, and help determine optimal conditions for cell culture growth. The products used include instruments and detection kits, applied in areas such as regenerative medicine and therapy development, drug discovery and development, and clinical research. End users include government research institutes, private research institutes, and industrial research organizations.
The stem cell assay market consists of sales of tetrazolium reduction assays, resazurin cell viability assays, calcein-AM cell viability assays, proliferation assays, differentiation assays, function assays, caspase assays and annexin v and cell permeability assays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Stem Cell Assay Market Characteristics
3. Stem Cell Assay Market Supply Chain Analysis
4. Global Stem Cell Assay Market Trends and Strategies
5. Stem Cell Assay Market Analysis of End Use Industries
7. Global Stem Cell Assay Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Stem Cell Assay Total Addressable Market (TAM) Analysis for the Market
9. Stem Cell Assay Market Segmentation
10. Stem Cell Assay Market Regional and Country Analysis
11. Asia-Pacific Stem Cell Assay Market
12. China Stem Cell Assay Market
13. India Stem Cell Assay Market
14. Japan Stem Cell Assay Market
15. Australia Stem Cell Assay Market
16. Indonesia Stem Cell Assay Market
17. South Korea Stem Cell Assay Market
18. Taiwan Stem Cell Assay Market
19. South East Asia Stem Cell Assay Market
20. Western Europe Stem Cell Assay Market
21. UK Stem Cell Assay Market
22. Germany Stem Cell Assay Market
23. France Stem Cell Assay Market
24. Italy Stem Cell Assay Market
25. Spain Stem Cell Assay Market
26. Eastern Europe Stem Cell Assay Market
27. Russia Stem Cell Assay Market
28. North America Stem Cell Assay Market
29. USA Stem Cell Assay Market
30. Canada Stem Cell Assay Market
31. South America Stem Cell Assay Market
32. Brazil Stem Cell Assay Market
33. Middle East Stem Cell Assay Market
34. Africa Stem Cell Assay Market
36. Stem Cell Assay Market Competitive Landscape and Company Profiles
37. Stem Cell Assay Market Other Major and Innovative Companies
40. Stem Cell Assay Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Stem Cell Assay Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses stem cell assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for stem cell assay? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stem cell assay market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Assay Type: Cell Viability And Toxicity Assays; Cell Apoptosis Assays; Cell Function Assays; Cell Identification Assays; Isolation And Purification Assays; Cell Differentiation Assay; Other Types2) By Product: Instruments; Detection kit
3) By Application: Regenerative Medicine And Therapy Development; Drug Discovery And Development; Clinical Research
4) By End User: Government Research Institutes; Private Research Institutes; Industry Research
Subsegments:
1) By Cell Viability and Toxicity Assays: MTT Assay; Resazurin Assay; ATP Assay; LDH Release Assay2) By Cell Apoptosis Assays: Caspase Activity Assays; Annexin V Staining Assays; TUNEL Assay; Cell Death Detection Assays
3) By Cell Function Assays: Proliferation Assays; Migration And Invasion Assays; Differentiation Assays
4) By Cell Identification Assays: Flow Cytometry-Based Assays; Surface Marker Characterization; Immunocytochemistry Assays
5) By Isolation and Purification Assays: Magnetic-Activated Cell Sorting (MACS); Fluorescence-Activated Cell Sorting (FACS); Density Gradient Centrifugation
6) By Cell Differentiation Assay: Lineage-Specific Differentiation Assays; Gene Expression Analysis During Differentiation
7) By Other Types: 3D Culture Assays; High-Content Screening Assays; Biomarker Discovery Assays
Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; Becton Dickinson and Company; Bio-Rad Laboratories Inc.; PerkinElmer Inc.; Agilent Technologies Inc.; Promega Corporation; Cell Biolabs Inc.; Miltenyi Biotec GmbH; STEMCELL Technologies Inc.; Bio-Techne Corporation; Charles River Laboratories International Inc.; Hemogenix Inc.; Lonza Group AG; Takara Bio Inc.; Creative Bioarray; AAT Bioquest Inc.; BPS Bioscience Inc.; Enzo Life Sciences Inc.; PromoCell GmbH; Biotium Inc.; Geno Technology Inc.; Abcam plc; ReachBio Research Labs. Inc.; Sartorius AG; Eppendorf AG; Corning Incorporated; MEDIPOST Co. Ltd.; Anterogen Co. Ltd.; Corestemchemon Inc.; Pharmicell Inc.; NuVasive Inc.; RTI Surgical Holdings Inc.; AlloSource LifeSource Services Inc.; JCR Pharmaceuticals Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Stem Cell Assay market report include:- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Becton Dickinson and Company
- Bio-Rad Laboratories Inc.
- PerkinElmer Inc.
- Agilent Technologies Inc.
- Promega Corporation
- Cell Biolabs Inc.
- Miltenyi Biotec GmbH
- STEMCELL Technologies Inc.
- Bio-Techne Corporation
- Charles River Laboratories International Inc.
- Hemogenix Inc.
- Lonza Group AG
- Takara Bio Inc.
- Creative Bioarray
- AAT Bioquest Inc.
- BPS Bioscience Inc.
- Enzo Life Sciences Inc.
- PromoCell GmbH
- Biotium Inc.
- Geno Technology Inc.
- Abcam plc
- ReachBio Research Labs. Inc.
- Sartorius AG
- Eppendorf AG
- Corning Incorporated
- MEDIPOST Co. Ltd.
- Anterogen Co. Ltd.
- Corestemchemon Inc.
- Pharmicell Inc.
- NuVasive Inc.
- RTI Surgical Holdings Inc.
- AlloSource LifeSource Services Inc.
- JCR Pharmaceuticals Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.48 Billion |
| Forecasted Market Value ( USD | $ 7.74 Billion |
| Compound Annual Growth Rate | 22.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 37 |
